Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care

BACKGROUND: The safety of restarting angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) after acute kidney injury (AKI) is unclear. There is concern that previous users do not restart ACEI/ARB despite ongoing indications. We sought to determine the risk of adve...

Descripción completa

Detalles Bibliográficos
Autores principales: Bidulka, Patrick, Fu, Edouard L., Leyrat, Clémence, Kalogirou, Fotini, McAllister, Katherine S. L., Kingdon, Edward J., Mansfield, Kathryn E., Iwagami, Masao, Smeeth, Liam, Clase, Catherine M., Bhaskaran, Krishnan, van Diepen, Merel, Carrero, Juan-Jesus, Nitsch, Dorothea, Tomlinson, Laurie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389346/
https://www.ncbi.nlm.nih.gov/pubmed/32723383
http://dx.doi.org/10.1186/s12916-020-01659-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389346/
https://www.ncbi.nlm.nih.gov/pubmed/32723383
http://dx.doi.org/10.1186/s12916-020-01659-x

Ejemplares similares